High‐intensity focused ultrasound: Safety and efficacy of a novel treatment modality for neurofibromatosis type 1 cutaneous neurofibroma

• Ngā kaituhi matua: Sirkku Peltonen (Author), Jørgen Serup (Author), Mimmi Tang (Author), Martin Gillstedt (Author), Despoina Kantere (Author), Noora Neittaanmäki (Author), Peter Holmström (Author), Jaishri O. Blakeley (Author), Karli Rosner (Author), Joshua Roberts (Author), Torsten Bove (Author), Katrine Elisabeth Karmisholt (Author)
• Hōputu: Pukapuka
• I whakaputaina: Wiley, 2024-09-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Abstract Background High‐intensity focused ultrasound (HIFU) is widely used in the treatment of deep tumours, but clinical trials on skin tumours are not yet available. Neurofibromatosis Type I (NF1) is among the most common single‐gene inherited conditions worldwide and predisposes to benign and ma...